With a significant increase in rabies exposures this year, Rodney Rohde, PhD, talks about seeking medical attention after animal interactions as well as clinical treatment when people have been bit or scratched.
|Videos|January 24, 2019
Is Severe Influenza a Risk Factor for Aspergillosis?
Author(s)Contagion® Editorial Staff
Mitsuru Toda, MS, PhD, discusses research that discovered 94 patients who had invasive aspergillosis with influenza.
Advertisement
Segment Description: Mitsuru Toda, MS, PhD, from the US Centers for Disease Control and Prevention (CDC) Mycotic Diseases Branch, along with her team, discovered 94 patients who had invasive aspergillosis with influenza.
Interview Transcript (modified slightly for readability):
Toda: We looked at national influenza surveillance in 30 different sites and 30 different states among a 12-year period. We saw among 92,000 patients there were 94 patients who had invasive aspergillosis with influenza and this number seems a little low, but when you look at publications in the past 60 years, only 57 cases have been described globally, so we thought that was pretty striking.
In in the study that we looked at — it was national influenza surveillance – and we looked at ICD codes which, we know is not a good indicator to look at for infection and we think that clinicians need to be more aware of this issue and also that fungal diseases should be diagnosed more. So, in order to improve surveillance diagnosing fungal infections would be really key.
Advertisement
Related to this article
In the first episode of our new series looking at the food safety network, Lynette Johnston, PhD, offers insights into how the federal government surveillance infrastructure operates and how epidemiologists serve as food detectives in determining bacterial pathogens and potential foodborne outbreaks.
Food expert Lynette Johnston, PhD, provides some context around the ongoing outbreak, discusses prevention, and compares 2026 food recalls with previous years.
The Peggy Lillis Foundation will host its 17th Annual Changing the Odds Gala this month in New York City, and it will include a casino, fellowship amongst the C diff community, and an award ceremony honoring a physician-scientist, philanthropist, a researcher, and a patient advocate for their contributions to C difficile awareness, treatment, and prevention.
Preliminary REMAP-CAP data suggesting oseltamivir may increase mortality in critically ill ICU influenza patients has sparked polarized reactions, but clinicians should await the full peer-reviewed manuscript before drawing broad conclusions, since the signal comes from a narrow, severely ill population and may reflect a therapeutic window effect rather than a blanket lack of efficacy.
Resistance-guided testing targeting a single gene mutation could let clinicians safely reintroduce ciprofloxacin for the majority of gonorrhea cases still susceptible to it, sparing ceftriaxone as resistance climbs worldwide. Lao-Tzu Allan-Blitz, MD, MPH, offers insights into his work in this area.
In the third episode of the series with Perry N. Halkitis, PhD, MS, MPH, he discusses how human behavior as well as other factors play a significant role in repeating outbreaks.
The Vaccine Integrity Project, in collaboration with the American Medical Association, conducted a vaccine and immunization effectiveness and safety review for RSV, Influenza, and COVID-19 for the 2026-2027 season. JAMA published the review, and here is an overview of the data going into this year's seasonal respiratory virus season.
Advertisement
Advertisement
Trending on Contagion Live
1
CDC Tracking 4 Active Foodborne Outbreaks
2
IDSA/ESCMID Statement on Staphylococcus aureus: Follow-Up Blood Cultures
3
Measles Update: September 25, 2026
4
On World Rabies Day, When to Seek Treatment, Clinical Considerations for Post Exposure Prophylaxis
5